3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
Clinical trial NCT00275444 · COMPLETED
Trial details
- NCT number
- NCT00275444
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-29
- Primary completion
- 2003-01-20
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.